Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain

Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain

Objectives: The aim of this study was to describe the tolerability, safety, and effectiveness of ocrelizumab for primary progressive multiple sclerosis (PPMS) and relapsing multiple sclerosis (RMS) in a clinical practice setting.Methods: In this retrospective observational study, we analyzed clinica...

Full description

Bibliographic Details
Main Authors: Angel P. Sempere, Leticia Berenguer-Ruiz, Ines Borrego-Soriano, Amparo Burgos-San Jose, Luis Concepcion-Aramendia, Lucian Volar, Miguel Aragones, Antonio Palazón-Bru
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
drug therapy
ocrelizumab
safety
tolerability
real-world
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.592304/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2020.592304/full

Similar Items